A novel synthetic lethal target for ATM inhibitors in pancreatic cancer
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic cancer treatment.
AI-powered MRI predicts outcomes in prostate cancer
Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.
Advances in neutropenia research could pave the way for better treatments
Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood.
Machine learning identifies key genes linking rheumatoid arthritis and osteoporosis
Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to the cartilage and bone.
Ancient herb shows promise in fighting dementia
Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products can offer hints for preventive medicine.
AI outperforms doctors in diagnostics but falls short as a clinical assistant
Researchers investigate whether large language models could enhance the diagnostic reasoning of physicians
Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy
A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.
Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project
Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.
Radiology: Myths and Facts - Greater Kashmir
Myth 1: Radiology is only about X-rays. Fact: While X-rays are one of the earliest imaging modalities, radiology encompasses a wide range of techniques, including…
New active substance shows promise in treating acute sudden hearing loss
A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss. The latest results have been published in the scientific journal "Cell Death & Disease".
Modulating CD39 expression to enhance CAR-T cell therapy against hepatocellular carcinoma
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in modulating the function of CAR-T cells.
AI-powered ECG model predicts heart disease risk with precision
A new AI-enhanced ECG model, AIRE, accurately predicts mortality and heart disease risk, providing clinicians with actionable, patient-specific insights.
Advanced deep learning technique enhances choroidal vessel visualization
Researchers from Peking University have developed a novel noninvasive choroidal angiography method that enables layer-wise visualization and evaluation of choroidal vessels using deep learning.
New targets identified for treating glioblastoma through genetic screen
A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer.
Two key genes identified linking rheumatoid arthritis and osteoporosis
Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for treatments. Drawing from a large database of genetic information, they gathered dozens of sequenced genomes from people with rheumatoid arthritis and osteoporosis to look for any similarities, using recently developed computational methods to narrow down their search. They identified genes ATXN2L and MMP14 as significantly associated with the progression of both rheumatoid arthritis and osteoporosis.
Using a molecular testing technology for faster and comprehensive diagnosis of brain tumors
Cancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in children.
last updated on 6 Nov 11:17